AlphaSense, the AI search and market intelligence platform that underpins critical decisions for thousands of global companies, has secured $350.0M in new investment.
The New York-based firm, which counts 88% of the S&P 100 and all 20 of the world’s largest pharmaceutical firms among its 6,500 clients, helps leaders move faster with greater confidence. Its latest capital infusion comes from a notable roster of backers including Vitruvian Partners, Accenture, J.P. Morgan, The D. E. Shaw Group, Pinegrove Opportunity Partners, CapitalG, Goldman Sachs, and Viking Global Investors.
